[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575791":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":22,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":10,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":10,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients undergoing ERCP according to normal clinical practice",null,"The validation of the present predictive model and the one already published in the Literature will involve the simple application of the two models to a cohort of patients (so-called validation group), undergoing ERCP according to normal clinical practice; therefore, there will be no interventions that would may alter the patient's normal course of treatment.",[13],{"name":14,"affiliation":5,"role":15},"Lorenzo Lorenzo, MD","PRINCIPAL_INVESTIGATOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Lorenzo Fuccio, MD","CONTACT","0512143338","lorenzo.fuccio@aosp.bo.it",[23],{"facility":5,"status":24,"city":25,"state":10,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Bologna","40138","Italy","IT",{"type":30,"coordinates":31},"Point",[32,33],11.33875,44.49381,{"lat":33,"lon":32},[36],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100575791","observational-study-to-develop-a-predictive-score-for-adverse-events-post-ercp-100575791",false,"NCT06776874","Observational Study to Develop a Predictive Score for Adverse Events Post ERCP","Studio Osservazionale Per lo Sviluppo di Uno Score Predittivo Degli Eventi Avversi Post-colangiopancreatografia Retrograda Endoscopica (ERCP)","Inclusion Criteria:\n\n* Age \\>18 years\n* Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP\n* Obtaining informed consent\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":49,"type":50},981,"ESTIMATED","OBSERVATIONAL","The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.",[54],"Endoscopic Retrograde Cholangiopancreatography","2025-01-14",{"date":57,"type":58},"2025-01-15","ACTUAL",{"date":60,"type":58},"2021-03-24",{"date":62,"type":50},"2025-12-31",{"name":5,"class":6},1]